首页> 美国卫生研究院文献>Memrias do Instituto Oswaldo Cruz >Oseltamivir-resistant influenza A(H1N1)pdm2009 strains found in Brazilare endowed with permissive mutations which compensate the loss of fitness imposedby antiviral resistance
【2h】

Oseltamivir-resistant influenza A(H1N1)pdm2009 strains found in Brazilare endowed with permissive mutations which compensate the loss of fitness imposedby antiviral resistance

机译:在巴西发现耐Oseltamivir的甲型H1N1流感pdm2009毒株被赋予了允许的突变以补偿所施加的适应性丧失通过抗病毒耐药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The 2009 pandemic influenza A virus outbreak led to the systematic use of the neuraminidase (NA) inhibitor oseltamivir (OST). Consequently, OST-resistant strains, carrying the mutation H275Y, emerged in the years after the pandemics, with a prevalence of 1-2%. Currently, OST-resistant strains have been found in community settings, in untreated individuals. To spread in community settings, H275Y mutants must contain additional mutations, collectively called permissive mutations. We display the permissive mutations in NA of OST-resistant A(H1N1)pdm09 virus found in Brazilian community settings. The NAs from 2013 are phylogenetically distinct from those of 2012, indicating a tendency of positive selection of NAs with better fitness. Some previously predicted permissive mutations, such as V241I and N369K, found in different countries, were also detected in Brazil. Importantly, the change D344N, also predicted to compensate loss of fitness imposed by H275Y mutation, was found in Brazil, but not in other countries in 2013. Our results reinforce the notion that OST-resistant A(H1N1)pdm09 strains with compensatory mutations may arise in an independent fashion, with samples being identified in different states of Brazil and in different countries. Systematic circulation of these viral strains may jeopardise the use of the first line of anti-influenza drugs in the future.
机译:2009年的甲型流感大流行爆发导致系统性使用神经氨酸酶(NA)抑制剂奥司他韦(OST)。因此,在大流行之后的几年中出现了带有突变H275Y的OST抗性菌株,流行率为1-2%。当前,在社区环境中未治疗的个体中发现了抗OST菌株。为了在社区环境中传播,H275Y突变体必须包含其他突变,这些突变统称为许可突变。我们显示在巴西社区环境中发现的耐OST的A(H1N1)pdm09病毒的NA中的允许突变。 2013年的NA在系统发育上与2012年不同,这表明积极选择具有更好适应性的NA的趋势。在巴西也发现了一些先前预测的允许突变,例如在不同国家发现的V241I和N369K。重要的是,在巴西发现了D344N变化,该变化也预示着可以弥补H275Y突变造成的适应性丧失,但在2013年却未在其他国家/地区发现。我们的结果进一步证实了具有代偿性突变的OST抗性A(H1N1)pdm09菌株可能样品以独立的方式产生,样品在巴西不同州和不同国家进行鉴定。这些病毒株的系统性循环将来可能会危害第一线抗流感药物的使用。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号